Cargando…
Chloroquine-induced QTc prolongation in COVID-19 patients
BACKGROUND: In the battle against the SARS-CoV‑2 pandemic, chloroquine has emerged as a new potential therapeutic option for the treatment of infected patients. A safety consideration for the application of chloroquine is its QTc-prolonging potential. Thus far, no data are available on the QTc-prolo...
Autores principales: | van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., van de Garde, E. M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189353/ https://www.ncbi.nlm.nih.gov/pubmed/32350818 http://dx.doi.org/10.1007/s12471-020-01429-7 |
Ejemplares similares
-
QTc Prolongation in COVID-19 Patients Using Chloroquine
por: Becker, Matthijs L., et al.
Publicado: (2021) -
QTc interval prolongation, COVID-19 and chloroquine
por: Wiwanitkit, V.
Publicado: (2020) -
Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
por: Brüggemann, R.J., et al.
Publicado: (2021) -
QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
por: Grewal, Sarah, et al.
Publicado: (2020) -
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine
por: Sinkeler, F. S., et al.
Publicado: (2020)